P
Über
Co-founder, CEO and President of Neurimmune. Key opinion leader in neurodegenerative diseases. Pioneer in therapeutic approaches for neurodegenerative diseases; inventor and developer of aducanumab in partnership with Biogen, first disease-modifying treatment and first approved therapy in over two decades for Alzheimer disease. Professor emeritus at Institute for Regenerative Medicine, University of Zurich. Potamkin prize winner; member of German Academy of Sciences. MD from University of Heidelberg.
Schwerpunkte
Diagnostics, Biopharma, Biotech, Life Sciences
Region
📍 Ansässig in Zurich, Switzerland
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...